Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
87.75
+2.23 (2.61%)
Jan 30, 2025, 4:00 PM EST - Market closed
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $6.23 billion as of January 30, 2025. Its market cap has increased by 33.23% in one year.
Market Cap
6.23B
Enterprise Value
5.07B
1-Year Change
33.23%
Ranking
Category
Stock Price
$87.75
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $6.23B, an increase of 683.31%. That is a compound annual growth rate of 79.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2025 | 6.08B | 9.25% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.84B |
| UnitedHealth Group | 499.24B |
| Novo Nordisk | 378.93B |
| Johnson & Johnson | 362.06B |
| AbbVie | 308.91B |
| Merck & Co. | 246.51B |
| Thermo Fisher Scientific | 223.49B |
| Abbott Laboratories | 220.95B |